| Nutropin AQ (somatropin) / Ipsen, Roche |
2009-012089-30: Frequency and mechanisms of resistance to IGF-1 generation in non-GH deficient short children with low IGF-1 concentration |
|
|
| Ongoing | 4 | 50 | Europe | Nutropin AQ, Solution for injection, Nutropin AQ | UZ Brussel | Prepubertal children with stature < -2 SDS, IGF-1 < the lowest reference limit and normal growth hormone response to an ITT or glucagon test | | | | |
2010-019735-35: Effets du traitement substitutif par hormone de croissance chez les patients présentant un déficit somatotrope sévère secondaire à un traumatisme crânien |
|
|
| Ongoing | 4 | 120 | Europe | NutropinAq, Nutropin Aq, Nutropin Aq | CHU Amiens | Déficit somatotrope de l\'adulte consécutif à un traumatisme crânien | | | | |
2014-000563-41: ?Recombinant hGH Biomarkers Discovery? Estudio de biomarcadores indicativos de la exposición a hormona de crecimiento recombinante |
|
|
| Ongoing | 4 | 72 | Europe | NutropinAq, NutropinAq, NutropinAq | Consorci Mar Parc de Salut de Barcelona (Parc de Salut Mar), World Anti-doping Agency | Healthy volunteers. There is not intended indication. Este estudio se realizará en voluntarios sanos sin ninguna patología concurrente. | | | | |
NCT06103513: Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children |
|
|
| Recruiting | 3 | 50 | US | Somatropin, Norditropin, Nutropin AQ, Genotropin, Zomacton, Humatrope, Omnitrope. | Northwell Health | Growth Disorders, Growth Failure, Growth Hormone Treatment, Growth | 06/25 | 12/25 | | |
2010-022215-19: Combined growth hormone and IGF1 therapy in paediatric Crohn'd disease |
|
|
| Ongoing | 2 | 24 | Europe | Increlex 10mg/ml solution for injection, NutropinAq 10mg/2ml solution for injection, Solution for injection, Increlex, NutropinAq® | Greater Glasgow & Clyde NHS | Impaired growth in Paediatric Crohn's disease, Impaired growth in Paediatric Crohn's disease, Diseases [C] - Digestive System Diseases [C06] | | | | |
2011-005377-23: Study for the assesment of the efficacy and safey of NUTROPIN® in patients with spinal cord injury (SCI) and growth hormone deficiency (GHD). Estudio para la evaluación de la eficacia y seguridad de NUTROPIN® en pacientes con lesión en la médula espinal (SCI) y deficiencia de la hormona de crecimiento (GHD) |
|
|
| Ongoing | 2 | 20 | Europe | NutropinAq 10 mg/2 ml (30 UI), NUTROPIN, NUTROPIN | Guillem Cuatrecasas Cambra, Ipsen Pharma, S.A. | Spinal Cord Injury and Growth Hormone Deficiency Lesión medular espinal y deficiencia de la hormona de crecimiento | | | | |